Clinical Trial Update: TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update exploring therapeutic drug monitoring-based infliximab treatment for active perianal fistulizing Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Perianal Fistulizing Crohn Disease

Drugs mentioned

• Remicade (infliximab) (infliximab)

Snippet

Sponsor: Asan Medical Center | Conditions: Crohn Disease, Infliximab | Phase 4 | Status: RECRUITING